| 1 |
How does the concept of “model as a dataset” reshape traditional data-sharing practices in medical imaging?
|
It enables sharing of learned model weights instead of sensitive raw images. |
|
The article explains that generative AI can support privacy-preserving multicentre collaboration by allowing researchers to share trained model knowledge rather than sensitive patient images. This reduces privacy risks while maintaining the utility of medical imaging data. |
This answer is based on the Model as a Dataset and privacy-preserving data-sharing concepts discussed in the Abstract and Introduction. The article highlights synthetic datasets, anonymisation, and privacy-preserving multicentre collaborations, which enable sharing learned model weights instead of raw medical images. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which analytical conclusion can be drawn about the trade-offs between physics-informed and statistical models?
|
Physics-informed models are more interpretable but computationally intensive. |
|
Physics-informed models incorporate imaging physics and therefore provide greater interpretability and consistency with image acquisition processes. However, they are generally more computationally demanding than purely statistical generative models. |
This conclusion is based on the trade-off between explainability and computational complexity described in the discussion of physics-informed and statistical generative models. Physics-informed approaches integrate domain-specific imaging physics, improving interpretability, while statistical models rely primarily on data-driven learning. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is “mode collapse” considered a critical problem in GAN-based medical image synthesis?
|
It reduces image realism and variety by producing repetitive outputs. |
|
Mode collapse occurs when a GAN repeatedly generates similar samples and fails to capture the full diversity of the training data. This reduces sample variety and limits the model's ability to represent different anatomical and pathological patterns in medical images. |
The article discusses the Generative AI Trilemma, which balances quality, diversity, and speed. GANs can generate high-quality images efficiently but may suffer from mode collapse, resulting in restricted diversity and repetitive outputs.
Citation Location
Page 2, right column, last paragraph under Synthetic datasets
Page 4, Figure 2 (Image Generation Trilemma) and its caption |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why are healthcare-specific metrics preferred over general-purpose metrics such as FID or SSIM?
|
They better capture clinical accuracy and diagnostic relevance. |
|
Healthcare-specific metrics are specifically designed for evaluating medical images. They can determine whether generated images preserve important anatomical structures and diagnostically relevant information. In contrast, general-purpose metrics such as FID and SSIM mainly measure visual similarity and technical image quality, which may not fully reflect the clinical usefulness or diagnostic value of the generated images. |
Healthcare-specific metrics are preferred because they evaluate whether synthetic medical images preserve important anatomical structures and clinically relevant information needed for diagnosis. Unlike general-purpose metrics such as FID and SSIM, which mainly measure visual similarity and image quality, healthcare-specific metrics focus on clinical relevance and diagnostic utility. This makes them more suitable for assessing the quality of medical images generated by AI.
Principle/Theory: Health-care-specific metrics for evaluating clinical relevance and diagnostic utility in medical image generation.
Location in the article in Page 5, section Health-care-specific metrics, first paragraph.
Supporting evidence: The authors state that healthcare-specific metrics are needed because disease classifiers may rely on local anatomical features rather than global image features. They also emphasize preserving crucial structures such as organs and lesions and note that standard metrics often fail to reflect clinical relevance or diagnostic utility (Khosravi et al., 2025). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the article identify as the key tension between privacy preservation and image fidelity?
|
Higher realism may risk reproducing identifiable patient data. |
|
The article explains that while synthetic medical images can help protect patient privacy, highly realistic images may unintentionally reproduce information from the original training data. If a generative model creates images that closely resemble real patients, there is a risk of re-identification and disclosure of sensitive patient information. Therefore, researchers must balance image fidelity (realism and quality) with privacy preservation when developing and evaluating synthetic medical datasets. |
The article discusses the ethical tension between generating highly realistic medical images and protecting patient privacy. Increasing image fidelity may improve clinical usefulness, but it can also increase the risk that synthetic images reveal or replicate identifiable patient information from the source dataset.
Location in the Article
Page: 7–8
Section: Patient privacy and data copying
Page 7: First paragraph
Page 8: First and second paragraphs |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is the FDA’s approval of synthetic MRI technology significant for future AI-generated data?
|
It establishes a framework for validating synthetic data equivalence in clinical use. |
|
The FDA’s approval of synthetic MRI technology is important because it demonstrates that AI-generated medical images can be evaluated and validated for clinical use. The article explains that regulatory approval requires evidence showing that synthetic images perform similarly to conventional images in diagnostic tasks. This approval provides a pathway for future AI-generated datasets by establishing standards for validation, safety, and clinical effectiveness rather than simply treating synthetic data as experimental research tools. |
The article discusses that future adoption of synthetic medical imaging depends on rigorous clinical validation and regulatory oversight. FDA approval serves as a precedent showing that synthetic images can be assessed against conventional medical images and approved when diagnostic performance is equivalent.
Location in the ArticlePage: 9
Section: Future directions
Paragraph: 3rd paragraph under Future directions (near the end of the article) |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which strategy would best mitigate demographic bias in generative models according to the article?
|
Applying diversity-aware training and fairness constraints |
|
The article explains that demographic bias in generative AI can occur when training data do not adequately represent all population groups. To reduce this problem, researchers should use diversity-aware sampling, fairness constraints, and bias-mitigation techniques during model development. These approaches help ensure that generated images represent different demographic groups more fairly and reduce the risk of discriminatory outcomes in medical applications. |
Bias Mitigation and Fairness in Generative AI
The article discusses that biases present in source datasets can be propagated or amplified in generated data. Therefore, fairness-aware model development is needed to improve representativeness and reduce demographic disparities in AI-generated medical images.
Location in the Article
Page: 8
Section: Potential biases
Paragraph: First paragraph under Potential biases |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How do DDPMs exemplify versatility in healthcare image synthesis?
|
They can perform multiple tasks such as denoising, inpainting, and anomaly detection without retraining. |
|
The article highlights that DDPMs (Denoising Diffusion Probabilistic Models) are highly versatile because they can be adapted to many medical imaging tasks beyond image generation. DDPMs have been used for denoising CT images, inpainting missing regions, creating diverse training samples, and even anomaly detection without additional fine-tuning. This flexibility allows the same trained model to support multiple downstream applications, making DDPMs especially valuable in medical imaging research and clinical workflows. |
Versatility Across Tasks of DDPMs
The article explains that DDPMs are multifunctional generative models whose learned representations can be reused for different tasks. Instead of training a new model for every application, the same diffusion model can be adapted for segmentation, inpainting, anomaly detection, and other healthcare imaging tasks.
Location in the Article
Evidence 1
Page: 6
Section: Versatility across tasks
Paragraph: First paragraph
Evidence 2
Page: 6
Section: Versatility across tasks
Paragraph: Second paragraph |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What analytical insight does the article provide about integrating AI-generated medical images into education and research?
|
It enhances training by providing diverse, realistic datasets without ethical breaches. |
|
The article explains that AI-generated medical images can improve education and research by providing diverse and realistic training datasets while protecting patient privacy. Synthetic images allow students and researchers to learn from rare diseases and different clinical scenarios without exposing sensitive patient information. This helps expand educational resources and supports research while reducing ethical concerns related to sharing real patient data. |
Privacy-Preserving Synthetic Data & Educational Augmentation
The article states that one of the major advantages of synthetic medical images is their ability to support medical education, research, and dataset diversification while preserving patient privacy. Synthetic datasets can mimic real clinical data without directly reproducing identifiable patient information.
Page 1, Abstract, Paragraph 1
Page 5, Potentials and Promises --> Increased Dataset Size and Diversity, Paragraph 1
Page 6, Privacy Preservation, Paragraph 1 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Why is regional calibration essential when applying risk prediction models across countries?
|
To adjust for population-specific incidence and lifestyle differences |
|
The article explains that Western-derived models like the Framingham Risk Score and PCE overestimate ASCVD risk in Chinese, Korean, and Japanese populations because CHD incidence is much lower in East Asia while stroke rates are higher.
Population-specific lifestyle and risk factor differences
The NCD-RisC data shows East Asian subgroups differ substantially in hypertension prevalence, cholesterol levels, obesity rates, and smoking patterns — all of which affect model accuracy.
Recalibration improves prediction accuracy
The CMCS cohort study demonstrated that recalibrating the Framingham equation using local population data substantially improved risk prediction accuracy. |
The article applies the principle of external validation and regional recalibration — a standard epidemiological concept stating that risk prediction models must be validated and adjusted using local cohort data to account for differences in baseline disease incidence, lifestyle factors, and risk factor distributions across populations.
Reference: Page 345 (Future Directions and Conclusions section), paragraph 1
ASCVD risk is significantly overestimated, in particular CHD, when applying calculators developed in the United States including the FRS and PCE. Unlike Europe and the United States, incidence of CHD is much lower while stroke rates are higher in Japan, Korea, and China.
Reference: Page 337 (Prevalence of ASCVD Risk Factors section), paragraph 3:
"South Korea had the lowest age-standardized prevalence of hypertension... Japanese people had the highest mean levels of total cholesterol... while Chinese people had the lowest mean levels of TC and HDL-C.
Reference: Page 339–340 (ASCVD Risk Prediction in China section):
"A recalibration of the Framingham Risk Score equation performed by replacing the corresponding estimations from CMCS cohort, substantially improved the accuracy of risk prediction. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What analytical conclusion can be drawn when comparing the China-PAR and Framingham models?
|
China-PAR uses local epidemiological data, leading to improved predictive validity. |
|
China-PAR achieves improved predictive validity over the Framingham model because it was developed and validated using native Chinese epidemiological cohort data (CMCS and China-MUCA), incorporating a Chinese-derived baseline survival function S₀_China(t), Chinese population mean risk factor values, and additional locally relevant predictors such as waist circumference and geographic region. This makes its calibration (E/O ratio closer to 1.0) significantly better than Framingham when applied to Chinese populations — the definitive criterion for superior predictive validity in a target population. |
Yang et al. & Xing et al. (China-PAR developers) — Table 1, Page 340Developed sex-specific ASCVD equations from Chinese cohorts; validated internally and externally
Liu et al. — Page 340Applied PCE and China-PAR to 226,406-person EHR cohort; demonstrated China-PAR's superior calibration
Wilson et al., 1998 (Framingham)Original model built on Framingham Heart Study — predominantly non-Hispanic White, not generalizable to Chinese populations
D'Agostino et al., 2008Demonstrated Framingham overestimates CVD risk in non-White populations when applied without recalibration |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Based on CVD mortality data, what analytical inference can be made about Japan’s position compared to neighboring countries?
|
Japan’s low CVD mortality suggests effective prevention and healthcare systems. |
|
Figure 1A (Page 335) shows Japan has the lowest age-standardized CVD mortality rate (77/100,000) among all five East Asian countries — nearly 7.5 times lower than Mongolia (578/100,000).
The article attributes this to three documented factors:
Structured national guidelines — JAS 2012, 2017, 2022 guidelines established systematic ASCVD prevention and absolute risk assessment (Page 341)
Universal healthcare coverage since 1961 enabling population-wide screening (Page 343)
World-leading CT infrastructure — 115.7 scanners per million population for early detection (Page 342)
These collectively support the inference of effective prevention and healthcare systems, not reporting bias, poor screening access, or data incomparability. |
GBD 2019 (Global Burden of Disease Study) — data source for Figure 1, Page 335Provides standardized international CVD mortality comparison; Japan's low rate is validated globally
Murray & Frenk (2000), WHO Health System PerformanceFramework linking low disease mortality to effective prevention and healthcare system performance
keda et al. (2011), LancetDocumented Japan's dramatic reduction in CVD mortality attributed to population-level blood pressure reduction through national health policy
Ueshima et al. (2008), CirculationExplained Japan's CVD paradox: low CHD despite high stroke historically — resolved by systematic hypertension control |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What analytical limitation arises when using Western-derived coefficients in East Asian models?
|
It introduces systematic overestimation of ASCVD probability. |
|
Risk factor weights calibrated to Western baseline incidence rates — which are fundamentally higher for CHD than in East Asia. Since the baseline CHD event rate in Western cohorts is substantially higher (Framingham 10-year CHD rate: 8.0% in men, 2.8% in women) compared to Chinese cohorts (CMCS: 1.5% in men, 0.6% in women), applying Western coefficients to East Asian individuals inflates predicted probability upward systematically — producing consistent overestimation across the entire population, not random error.
Key evidence (Page 339–340):
The article explicitly states the original Framingham equation significantly overestimated absolute CHD risk in the CMCS Chinese cohort. Similarly, PCE overpredicted risk in men in the 226,406-person EHR validation study. This pattern repeats across China, Japan, and Korea throughout the article — confirming the overestimation is systematic, not incidental. |
Theoretical & Mathematical Basis
Cox Model Coefficient Problem
The Cox Proportional Hazards model predicts risk as:
P(event) = 1 − S₀(t)^exp(β₁X₁ + β₂X₂ + ... + βₙXₙ)
When Western β coefficients are applied to East Asian individuals:
S₀(t) = Western baseline survival (lower, reflecting higher Western CHD incidence)
βᵢ = Western-derived weights (calibrated to higher-risk Western population)
Xᵢ = East Asian individual's actual risk factor values
Result: exp(Σβᵢ Xᵢ) is exponentiated against a lower Western S₀(t), systematically producing higher predicted risk than the true East Asian baseline warrants → Systematic overestimation
Supporting Theory
Steyerberg's Clinical Prediction Models (2009) — the foundational textbook establishing that prediction model transportability requires both coefficient recalibration AND baseline hazard adjustment when moving between populations with different baseline risks.
Harrell's Regression Modeling Strategies — states that applying coefficients beyond their derivation population introduces miscalibration bias, specifically overestimation when target population has lower baseline incidence. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What policy implication can be derived from country-specific risk models?
|
They allow for targeted national prevention programs. |
|
Country-specific risk models identify which risk factors are most prevalent and most predictive within a given national population. This enables health policymakers to design targeted interventions — allocating resources toward the highest-impact risk factors for that specific population rather than applying generic Western-derived strategies.Key evidence from the article:Page 340 (China): Chinese guidelines used CMCS/China-PAR models to establish national dyslipidemia treatment targets and blood pressure management thresholds — directly translating country-specific risk data into national prevention policy since 1999.Page 341–342 (Japan): JAS guidelines used the Suita score (Japan-specific model) to set population-stratified LDL-C targets — low-risk (<160 mg/dL), moderate-risk (<140 mg/dL), high-risk (<120 mg/dL) — enabling precisely targeted lipid-lowering programs at the national level.Page 343 (Korea): The Korean Society of Lipid and Atherosclerosis used Korean-specific cohort data (KOGES) to revise the 5th edition dyslipidemia guidelines, lowering LDL-C targets for high-risk groups — a targeted national policy change driven directly by country-specific model findings.Page 345–346 (Conclusions): The article explicitly calls for "disaggregated registry, cohort, and clinical trial data by East Asian subgroups...to initiate studies to better define ASCVD risk" — emphasizing that country-specific models are the foundation for targeted national prevention. |
Public Health Policy Theory
Country-specific risk models operationalize the Geoffrey Rose Preventive Strategy
Risk Stratification → Policy Translation Model
Country-Specific Model Output → Risk Stratification → Treatment Threshold → National Guideline → Prevention Program
WHO Global Action Plan for NCDs 2013–2030Mandates country-specific cardiovascular risk assessment tools for national NCD prevention programs
Rose G. (1985), Int J Epidemiology — "Sick Individuals and Sick Populations"Foundational theory: population-level prevention requires population-specific risk identification
Hippisley-Cox et al. (QRISK, UK)Demonstrated that country-specific models (QRISK vs Framingham) changed clinical treatment decisions for 15% of patients — validating targeted policy impact |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
If a model excludes socioeconomic variables, what analytical consequence might occur?
|
Ignored non-biological determinants of disease |
|
Socioeconomic variables — such as income, education, physical inactivity, dietary patterns, and access to healthcare — are non-biological determinants of disease that directly influence cardiovascular risk. When a prediction model excludes these variables, it captures only biological/clinical measurements (blood pressure, cholesterol, glucose) while missing the upstream social and behavioral drivers that shape those biological values in the first place.Key evidence from the article:Page 338 (Acculturation and Environmental Effects section):
The article explicitly states that risk factor tools for East Asian immigrants must consider immigration history, generational status, and acculturation effects on risk factor profiles — all socioeconomic/behavioral variables. Models that exclude these factors produce incomplete risk characterization.Page 338 (paragraph on physical inactivity):
Even after adjustment for age, sex, and socioeconomic factors, East Asian persons were more likely to be physically inactive (PR 1.14) — demonstrating that socioeconomic and lifestyle variables independently contribute to ASCVD risk beyond biological markers alone.Page 337 (NCD-RisC data):
The article notes that NCD-RisC percentages reflect U.S. population averages, limiting ability to compare East Asian persons — precisely because socioeconomic and lifestyle context differs, and models ignoring these factors cannot accurately represent subgroup risk.Page 345 (Conclusions):
The article calls for models that account for "acculturation, environmental factors, and cultural influences" — all non-biological determinants — confirming their analytical importance when excluded. |
Social Determinants of Health (SDH) Framework
The WHO Commission on Social Determinants of Health (2008) established that:
Health Outcomes = f(Biological Risk Factors) + f(Social Determinants)
Where Social Determinants include: income, education, occupation, physical environment, health behaviors, and access to care
Excluding socioeconomic variables from a prediction model creates omitted variable bias:
Omitted Variable Bias Formula:
β̂₁ = β₁ + β₂ · (δ₁₂)
Where:
β̂₁ = estimated coefficient of included variable
β₁ = true coefficient
β₂ = effect of omitted socioeconomic variable
δ₁₂ = correlation between included and omitted variables
When socioeconomic variables (correlated with biological risk factors) are omitted, included coefficients become biased — systematically misrepresenting true risk relationships. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How might AI improve next-generation ASCVD risk prediction in East Asia?
|
By integrating multimodal data, including imaging and lifestyle informa |
|
AI's primary advantage over traditional Cox regression models is its ability to simultaneously process multiple data types — structured clinical data, medical imaging, lifestyle/behavioral data, and biomarkers — that traditional models cannot efficiently combine. In East Asian ASCVD prediction specifically, this multimodal integration addresses the key limitation identified throughout the article: that single-domain models (using only traditional risk factors) miss important imaging-detected subclinical atherosclerosis and lifestyle-driven risk patterns. |
AI/ML Multimodal Integration Framework
Traditional ASCVD models use linear combination of structured variables:
Cox Model: P(event) = 1 − S₀(t)^exp(β₁X₁ + β₂X₂ + ... + βₙXₙ)
Limited to: age, sex, BP, cholesterol, smoking, diabetes
AI/Machine Learning models extend this to:
Deep Learning Risk Score = f(Clinical Data, Imaging Features, Lifestyle Variables, Biomarkers)
Where f() = neural network capable of capturing:
Non-linear relationships between variables
Interaction effects between imaging + clinical data
High-dimensional feature extraction from raw imaging
This multimodal architecture directly addresses the article's identified gaps in East Asian risk prediction. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What conclusion can be drawn from comparing Mongolia’s and South Korea’s CVD mortality rates?
|
Mortality differences reflect varying effectiveness of national prevention programs.Mortality differences reflect varying effectiveness of national prevention programs. |
|
From Figure 1A (Page 335), the age-standardized CVD mortality gap between Mongolia and South Korea is stark: CountryAge-Standardized CVD MortalityMongolia578/100,000South Korea95/100,000This is a 6-fold difference between two geographically proximate East Asian nations with broadly similar ethnic backgrounds. Since genetic differences alone cannot explain a 6-fold mortality gap, the most analytically sound conclusion is that national prevention program effectiveness — health policy, screening infrastructure, clinical guidelines, and healthcare access — drives this difference. |
Epidemiological Transition Theory
Omran's Epidemiological Transition Model (1971) explains CVD mortality differences between nations through stages of health system development:
Stage 3 (Degenerative diseases): High CVD mortality — Mongolia
Stage 4 (Delayed degenerative diseases): Low CVD mortality through prevention — South Korea
South Korea has advanced to Stage 4 through systematic primary and secondary prevention programs, while Mongolia remains at Stage 3 with limited prevention infrastructure.
Prevention Effectiveness Framework
CVD Mortality Rate = Baseline Incidence × (1 − Prevention Effectiveness)
Where Prevention Effectiveness = f(Screening Coverage + Treatment Access + Guideline Adherence + Health Literacy)
This formula explains why identical baseline risk populations can have vastly different mortality outcomes based on national prevention program quality. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the most logical future direction for improving ASCVD models across East Asia?
|
Establishing multinational data-sharing platforms to harmonize regional models |
|
The article's entire conclusion section converges on one core argument: no single East Asian country's model can be generalized across the region because China, Japan, and Korea each developed models independently using their own cohorts, with no cross-validation between countries. The logical solution is multinational collaboration through shared data platforms that allow harmonized model development, cross-validation, and regional standardization. |
Knowledge Synthesis & Research Harmonization TheoryThe FAIR Data Principles (Wilkinson et al., 2016) establish the framework for multinational research data sharing:
Data must be: Findable + Accessible + Interoperable + Reusable
Applied to East Asian ASCVD models:
Harmonized Regional Model = ∑(Country-Specific Cohort Data) with standardized:
Outcome definitions (ASCVD = CHD + stroke + PAD)
Risk factor measurement protocols
Follow-up duration
Validation methodology
Model Improvement Through Data PoolingStatistical power increases with pooled multinational data:
Standard Error (SE) = σ/√n
Where pooling China (n≈30,000) + Japan (n≈40,000) + Korea (n≈150,000+) cohorts dramatically reduces SE, improving coefficient precision and model generalizability across the region. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
According to the “image generation trilemma” shown in the figure, what analytical conclusion can be drawn about the relative strengths of VAEs, GANs, and DDPMs in medical image synthesis?
|
GANs provide a balance between image quality and diversity but may suffer from mode collapse. |
|
The diagram shows GANs positioned between Quality and Speed — not at the Diversity corner — meaning GANs sacrifice diversity for quality and speed. This positional trade-off is the defining characteristic of mode collapse: GANs generate high-quality images but from a limited distribution (low diversity), repeatedly producing similar outputs rather than capturing the full data distribution.The correct answer accurately describes GANs' dual strength (quality + speed balance) and their known critical weakness (mode collapse) — making it the only option that correctly interprets both the diagram position AND the underlying technical limitation. |
GAN Architecture and Mode Collapse Theory
Goodfellow et al. (2014) — original GAN paper — established the minimax framework:
GAN Objective:
min_G max_D V(D,G) = 𝔼[log D(x)] + 𝔼[log(1 − D(G(z)))]
Where:
G = Generator (creates synthetic images)
D = Discriminator (distinguishes real vs fake)
x = real data, z = random noise
Goodfellow et al. (2014), NeurIPSOriginal GAN paper establishing adversarial training and documenting mode collapse as fundamental limitation
Kingma & Welling (2013), ICLRVAE framework — established diversity-speed strength with quality limitation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on Figure, what analytical conclusion can be drawn regarding the distribution of cardiovascular disease (CVD) subtypes across East Asian countries?
|
Ischemic heart disease (IHD) accounts for a higher proportion of CVD deaths in Japan and South Korea compared with China, suggesting regional lifestyle or prevention differences. |
|
Key observation: China has the highest stroke proportion (48%) and lowest IHD proportion relative to stroke, while Japan and South Korea show relatively higher IHD proportions compared to their stroke burden. Additionally, Japan's stroke breakdown shows 63% ischemic vs 37% hemorrhagic, while China shows 50/50 — reflecting different pathophysiological patterns driven by lifestyle and prevention differences.The article directly attributes these subtype differences to regional lifestyle factors (hypertension control, cholesterol levels, dietary patterns) and prevention program effectiveness — not genetics alone. |
CVD Subtype Epidemiology TheoryFeigin et al. (GBD Stroke Collaborators) established that CVD subtype distribution reflects:
Stroke Proportion ∝ Hypertension Prevalence × Control Failure Rate
IHD Proportion ∝ Dyslipidemia Prevalence × Sedentary Lifestyle × Dietary Fat Intake
This formula explains why:
China: High stroke (48%) = highest hypertension burden + historically lower control rates
Japan/Korea: Higher relative IHD = better hypertension control (reducing stroke) but increasing Western dietary influence elevating IHD
GBD 2019 Stroke Collaborators — data source Figure 2Validated international CVD subtype proportional mortality methodologyFeigin et al. (2022), Lancet NeurologyEstablished lifestyle and prevention factors as primary drivers of stroke vs IHD proportion variation across AsiaUeshima et al. (2008), CirculationJapan's CVD epidemiological transition: declining stroke through hypertension control while IHD rises with Westernization of dietNCD-RisC (2017) — cited Page 337Documents country-specific risk factor profiles (HDL-C, TC, hypertension) explaining CVD subtype distribution differences |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|